Breaking News: Expert Perspective on Venclexta (venetoclax) Approval

Breaking News: Expert Perspective on Venclexta (venetoclax) Approval

The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Andrew Schorr interviewed CLL expert Dr. Thomas Kipps to get his perspective on what this new approval means for patients.  

patientpower.info/video/bre...

oldestnewest

You may also like...